Skip to content Skip to footer
Subscribe Now
PharmaShots Interview Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022
VIEWPOINTS
PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022
Shots:Kathy spoke about the major outcomes from the real-world evidence data presented at the ASCO 2022Kathy also emphasized on how next-generation sequencing can improve genomic testingThe interview gives a view of Thermo Fisher’s vision to bring targeted sequencing that provides faster results for cliniciansSmriti: Tell us in detail about the key…
July 20, 20220Comments
PharmaShots Interview Mahesh Karande, CEO of Omega Therapeutics Shares Insights from the Preclinical Data Presented at the AACR 2022
VIEWPOINTS
PharmaShots Interview: Mahesh Karande, CEO of Omega Therapeutics Shares Insights from the Preclinical Data Presented at the AACR 2022
Shots:Mahesh talked about the data presented on its lead candidate in hepatocellular carcinoma at the AACR 2022Mahesh also spoke about Omega’s drug-development platform that identifies and targets specific and unique DNA sequences of regulatory elements The interview gives a profound grip on Omega’s development strategies to use mRNA therapeutics as a new class…
July 19, 20220Comments
Exclusive_Barbara Klencke_2022
EXCLUSIVE
Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibrosis Study
Shots:Barbara gave a comprehensive view of the P-III (MOMENTUM) clinical study results which evaluates its lead candidate in myelofibrosisSierra is now acquired by GSK (completed on 1st July 2022) resulting in GSK commercializing this prime product once approvedThe interview outlines Sierra’s (now GSK) vision to develop transformative therapies for rare cancersSmriti: Thank…
July 18, 20220Comments
Innovative Digital Therapeutics Top 20 2021
TOP 20
Top Innovative Digital Therapeutics Companies of 2021
Shots:The past few years have shown an accelerated development in the digital therapeutics market through various applications, tracking devices, and telemedicine being integrated into digital therapiesDigital therapeutics provided powerful tools to maintain the public healthcare system during the Covid-19 pandemic for the people to access treatments for both physical & psychological conditions at home…
July 14, 20220Comments
PharmaShots Interview Dr. Bassem Maximos Shares Insights from New Research on Evofem’s Non-Hormonal Contraceptive Gel, P-III (AMPOWER) Study
VIEWPOINTS
PharmaShots Interview: Dr. Bassem Maximos Shares Insights from New Research on Evofem’s Non-Hormonal Contraceptive Gel, P-III (AMPOWER) Study
Shots:Bassem spoke about the new data presented in a poster presentation  at the ACOG annual meetingThe data was based on the P-III (AMPOWER) study, which evaluates Evofem’s nonhormonal contraceptive gel to prevent pregnancyThe interview gives an understanding of how Evofem is developing innovative products to improve women's health Smriti: Please highlight the study…
July 13, 20220Comments
Exclusive_Kyle Forcier_2022
EXCLUSIVE
Kyle Forcier, Senior Director of Life Sciences Product Marketing at Model N Shares Insights on How Model N Helps Life Sciences Companies Navigate Greater Compliance Pressure
Shots:Kyle Forcier gave a detailed view of the Spring 2022 product release by Model N and how it will be a practical solution for the Pharmaceutical and MedTech companiesKyle also spoke about Model N’s Revenue Cloud, which can empower MedTech Sales with better revenue recognitionThe interview gives a glimpse of Model N’s…
July 11, 20220Comments